European Medicines Agency Accepts Titan Pharmaceuticals' Marketing Authorization Application For Probuphine®

Stock Information for Titan Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Titan Pharmaceuticals Inc.

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock
Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets
Titan Pharmaceuticals Provides Shareholder Update
UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.
Titan Pharmaceuticals Announces Board Expansion and Management Changes

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.